問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-01-01 - 2029-12-12
Condition/Disease
Test Drug
Participate Sites12Sites
Recruiting12Sites
2019-01-01 - 2030-12-31
Participate Sites13Sites
Recruiting13Sites
2022-12-01 - 2026-06-30
Non-Small Cell Lung Cancer (NSCLC) 、Colorectal Cancer (CRC)、 Pancreatic Ductal Adenocarcinoma 、Advanced Solid Tumor
RMC-6291 Tablets 25/100 mg
Participate Sites5Sites
Not yet recruiting4Sites
Recruiting1Sites
2021-03-17 - 2035-12-31
Recruiting5Sites
2021-06-30 - 2022-12-31
Participate Sites1Sites
Terminated1Sites
2022-01-01 - 2024-12-31
Hepatocellular Carcinoma
液劑 錠劑
Participate Sites2Sites
Terminated2Sites
2022-10-31 - 2026-12-31
Recruiting2Sites
2006-03-01 - 2007-05-01
Terminated5Sites
2025-05-01 - 2043-05-01
2019-10-24 - 2021-03-08
Participate Sites4Sites
Division of Others-
全部
